|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| C07D 401/04 | (2006.01) | ||
| A61K 38/05 | (2006.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/69 | (2006.01) |
| (11) | Number of the document | 3651766 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18746444.1 |
| Date of filing the European patent application | 2018-07-09 | |
| (97) | Date of publication of the European application | 2020-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-11 |
| (46) | Date of publication of the claims translation | 2024-12-10 |
| (86) | Number | PCT/US2018/041230 |
| Date | 2018-07-09 |
| (87) | Number | WO 2019/014100 |
| Date | 2019-01-17 |
| (30) | Number | Date | Country code |
| 201762530778 P | 2017-07-10 | US | |
| 201762593185 P | 2017-11-30 | US | |
| 201862675581 P | 2018-05-23 | US |
| (72) |
ALEXANDER, Matthew, D. , US
ARTMAN, Gerald, D., III , US
BRAY, Gordon, L. , US
CARMICHAEL, James , GB
CARRANCIO, Soraya , US
CATHERS, Brian E. , US
CORREA, Matthew, D. , US
HANSEN, Joshua , US
HAVENS, Courtney, G. , US
KERCHER, Timothy, S. , US
LOPEZ-GIRONA, Antonia , US
LU, Xiaoling , US
MAN, Hon-Wah , US
NAGY, Mark, A. , US
NARLA, Rama, K. , US
PICCOTTI, Joseph, R. , US
PIERCE, Daniel, W. , US
TAVARES-GRECO, Paula, A. , US
WHITEFIELD, Brandon, W. , US
WONG, Lilly, L. , US
ZOU, Nanfei , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4-(4-(4-(((2-(2,6-dioksopiperidin-3-il)-1-oksoizoindolin-4-il)oksi) metil)benzil)piperazin-1-il)-3-fluorbenzonitrilas kaip antiproliferacinis junginys |
| 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-L-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-L-YL)-3-FLUOROBENZONITRILE AS ANTIPROLIFERATIVE COMPOUND |
| Payment date | Validity (years) | Amount | |
| 2025-05-09 | 8 | 185.00 EUR |
| 2026-07-09 |